K182574 is an FDA 510(k) clearance for the Freedom Ultra-Congruent CR Tibial Liner. This device is classified as a Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer (Class II - Special Controls, product code JWH).
Submitted by Maxx Orthopedics, Inc. (Norristown, US). The FDA issued a Cleared decision on January 22, 2019, 126 days after receiving the submission on September 18, 2018.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3560.